Valuation : Virbac

Market Cap 2.61B 3.03B 2.47B 2.24B 4.2B 289B 4.22B 29.35B 11.29B 147B 11.38B 11.13B 465B P/E 2026 *
15.2x
P/E 2027 * 13.7x
Enterprise Value 2.73B 3.17B 2.59B 2.35B 4.4B 303B 4.42B 30.75B 11.82B 154B 11.92B 11.66B 487B EV / Sales 2026 *
1.76x
EV / Sales 2027 * 1.63x
Free-Float
49.03%
Yield 2026 *
0.55%
Yield 2027 * 0.65%
1 week-2.20%
Current month-3.26%
1 month-8.38%
3 months-10.36%
6 months-7.98%
Current year-12.50%
1 week 300.5
Extreme 300.5
318.5
1 month 300.5
Extreme 300.5
340
3 years 243.5
Extreme 243.5
400
5 years 216.5
Extreme 216.5
446.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
+3.49%-2.20%-4.59%+16.45% 3.03B
+0.15%-3.75%-51.55%-60.78% 30.15B
+1.36%-5.43%+23.38%+96.69% 11.58B
-3.09%-1.28%-13.85%+1.93% 3.88B
+3.15%-2.35%-4.59%+17.55% 3.03B
-2.91%-4.96%+42.04%+24.89% 1.9B
-0.15%-0.29%+9.60%+25.28% 1.87B
-2.62%-6.88%-13.52%+180.25% 1.45B
-3.31%-2.60%-20.82%-6.36% 1.17B
-2.57%-1.01%-7.95%-41.52% 1.04B
Average -1.11%-3.75%-4.19%+25.44% 6.23B
Weighted average by Cap. +0.03%-3.91%-22.34%-5.05%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.47B 1.33B 2.49B 172B 2.51B 17.42B 6.7B 87.39B 6.75B 6.6B 276B 1.65B 1.91B 1.56B 1.41B 2.65B 182B 2.66B 18.5B 7.12B 92.82B 7.17B 7.01B 293B
Net income 172M 200M 163M 148M 277M 19.07B 278M 1.93B 744M 9.7B 749M 733M 30.65B 191M 222M 181M 164M 308M 21.18B 309M 2.15B 826M 10.77B 832M 814M 34.04B
Net Debt 124M 144M 118M 107M 200M 13.79B 201M 1.4B 538M 7.02B 542M 530M 22.17B 68.29M 79.26M 64.66M 58.61M 110M 7.57B 111M 768M 295M 3.85B 298M 291M 12.17B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Date Price Change
11/09/26 EUR 311.50 +3.49%
10/09/26 EUR 301.00 -2.43%
09/09/26 EUR 308.50 -2.37%
08/09/26 EUR 316.00 +0.64%
07/09/26 EUR 314.00 -1.41%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
311.50EUR
Average target price
411.88EUR
Spread / Average Target
+32.22%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!